Showcasing our technology platforms and scientific advancements
This episode was recorded in person at the JP Morgan Healthcare Conference in San Francisco. Biotech history buffs will especially enjoy the first half, where he talks about what pharmaceutical sales was like and what it was like to work at Amgen in the early days.
Read this PublicationAndrew Sandford and Michael Paglia are the President and COO, respectively, of ElevateBio BaseCamp®, a cell and gene therapy technology company powering transformative therapies. They join us from the company’s manufacturing facilities in Waltham, Massachusetts, for a discussion about the landscape of company creation in the cell and gene therapy space and how ElevateBio is helping companies bring innovation and therapeutics to clinics and patients to help treat and cure diseases.
Read this PublicationMike Paglia, COO BaseCamp®, on ‘Ori Spotlight’ podcast discussing how Elevate supports the cell and gene therapy industry, the long-term benefits of digital manufacturing processes, and the importance of removing the cost barrier to CGTs.
Read this PublicationAmit Mathur, CIO ElevateBio, on ‘Accelerating Clinical’ podcast, discussing the power of collective wisdom
Read this PublicationMelissa Carpenter, pHD, CSO Regenerative Medicine
Read this PublicationMario Miele, VP Facilities and Engineering, article discussing the buildout of BaseCamp®
Read this PublicationFrom gene editing to biomanufacturing, learn more about the cell and gene therapy industry from our team of industry-leading experts
January 2023
From our Chairman and CEO, David Hallal
Read MoreJune 2022
By: Mercedes Segura, Vice President, Process Development, ElevateBio, Dawn Maier, Vice President, Emerging Technologies, ElevateBio, and Bojiao Yin, Director of Vector Process Development, ElevateBio
Read MoreMay 2022
By Mike Paglia, Chief Operating Officer ElevateBio BaseCamp®
Read MoreApril 2022
By Adrian Oliver, Ph.D., Senior Scientist of Technology Development, Life Edit Therapeutics
Read MoreJune 2021
By Alexandra Crawley, PH.D., Co-founder and Principal Investigator, Life Edit Therapeutics, Inc.
Read More
